Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial
Open Access
- 19 April 2017
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 49 (4) , 1601814
Abstract
We evaluated the prevalence of significant lung abnormalities on computed tomography (CT) in patients who died from a respiratory illness other than lung cancer in the National Lung Screening Trial (NLST).In this retrospective case–control study, NLST participants in the CT arm who died of respiratory illness other than lung cancer were matched for age, sex, pack-years and smoking status to a surviving control. A chest radiologist and a radiology resident blinded to the outcome independently scored baseline CT scans visually and qualitatively for the presence of emphysema, airway wall thickening and fibrotic lung disease. The prevalence of CT abnormalities was compared between cases and controls by using chi-squared tests.In total, 167 participants died from a respiratory cause other than lung cancer. The prevalence of severe emphysema, airway wall thickening and fibrotic lung disease were 28.7%versus4.8%, 26.9%versus13.2% and 18.6%versus0.5% in cases and controls, respectively. Radiological findings were significantly more prevalent in deaths compared with controls (all p<0.001).CT-diagnosed severe emphysema, airway wall thickening and fibrosis were much more common in NLST participants who died from respiratory disease, and CT may provide an additional means of identifying these diseases.Keywords
This publication has 26 references indexed in Scilit:
- Impact of Cardiovascular Calcifications on the Detrimental Effect of Continued Smoking on Cardiovascular Risk in Male Lung Cancer Screening ParticipantsPLOS ONE, 2013
- Mortality by Level of Emphysema and Airway Wall ThicknessAmerican Journal of Respiratory and Critical Care Medicine, 2013
- The National Lung Screening Trial's Endpoint Verification Process: Determining the cause of deathContemporary Clinical Trials, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- CT Scan Findings of Emphysema Predict Mortality in COPDChest, 2010
- Association of Radiographic Emphysema and Airflow Obstruction with Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2008
- The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UKRespiratory Medicine, 2007
- A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe EmphysemaNew England Journal of Medicine, 2003